Zobrazeno 1 - 10
of 76
pro vyhledávání: '"L I Benevolenskaya"'
Autor:
Elena Vasilyevna Chetina, M Yu Krylov, N V Demin, O A Nikitinskaya, E A Korotkova, N V Toroptsova, K A Maslova, L I Benevolenskaya, V A Myakotkin
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 2, Pp 50-55 (2012)
Objective: to study the mechanism for the involvement of ТGFβ1 T(861-20)C in bone resorption in postmenopausal osteoporosis (OP). Material and methods. DNA from 158 postmenopausal women and patients with OP and from 89 healthy age-matched women was
Externí odkaz:
https://doaj.org/article/42ff35ae7f5a4f7b8cba7b4123a07ac2
Autor:
V A Myakotkin, M Yu Krylov, I A Guseva, E V Chetina, N V Toroptsova, O A Nikitinskaya, E Yu Samarkina, L I Benevolenskaya
Publikováno v:
Научно-практическая ревматология, Vol 49, Iss 2, Pp 15-20 (2011)
Polymorphisms of 21 genes involved in the processes of bone remodeling were studied on samples of 150 to 265 postmenopausal healthy women in a control group and those of 175 to 269 patients with osteoporosis (OP). In a Moscow sample of postmenopausal
Externí odkaz:
https://doaj.org/article/0b55568ba9cd444088f487742a20e939
Publikováno v:
Научно-практическая ревматология, Vol 48, Iss 5, Pp 27-31 (2010)
Objective: to study an association of leptin (LEP) A19G polymorphism and leptin receptor (LEPR) Gln223Arg AND Lys109Arg polymorphisms with the predilection for postmenopausal osteoporosis (OP). Subjects and methods. PCR analysis was used to examine t
Externí odkaz:
https://doaj.org/article/77a93cc1541c421c8dc88a459ec1e5a0
Publikováno v:
Научно-практическая ревматология, Vol 48, Iss 5, Pp 14-18 (2010)
Externí odkaz:
https://doaj.org/article/8e0fb0713f9b4ac2ade9ae1d654b6b51
Publikováno v:
Научно-практическая ревматология, Vol 48, Iss 1, Pp 46-50 (2010)
A chronic inflammatory process is one of the risk factors of secondary osteoporosis (OP) and its related fractures. Determination of the level of C-reactive protein (CRP) is used to estimate the magnitude of an inflammatory reaction. The developed hi
Externí odkaz:
https://doaj.org/article/7a223aae81e54f4e923d73bbdd80354c
Publikováno v:
Научно-практическая ревматология, Vol 47, Iss 4, Pp 32-40 (2009)
Objective. To assess possible relationship between osteoporosis and cardiovascular diseases in women of postmenopausal period considering clinical and laboratory data. Material and methods. 98 postmenopausal women aged 45 to 70 years were included (5
Externí odkaz:
https://doaj.org/article/b7c9b52cc457498883ca25804428aa24
Autor:
M Y Krylov, K A Maslova, T A Korotkova, N A Toroptsova, O A Nikitinskaya, N V Demin, V A Myakotkin, L I Benevolenskaya
Publikováno v:
Научно-практическая ревматология, Vol 47, Iss 1, Pp 18-23 (2009)
Objective. Transforming growth factor β1 (TGF β1) prevails among growth factors in bone. It is produced by osteoblasts and is able to hamper osteoclast proliferation, activate and stimulate osteoblasts precursors proliferation and differentiation.
Externí odkaz:
https://doaj.org/article/c7a14b331b294312bc4955d494ed33f9
Autor:
N V Toroptsova, O A Nikitinskaya, T A Korotkova, N V Demin, A V Smirnov, L I Benevolenskaya, L Y Rozinskaya, S. S. Rodionova
Publikováno v:
Научно-практическая ревматология, Vol 46, Iss 3, Pp 23-29 (2008)
Strontium ranelate (Bivalos) is a new drug with dual mechanism of action for the treatment of postmenopausal osteoporosis (OP) Objective. To assess efficacy and tolerability of bivalos in women with postmenopausal osteoporosis in a one year multicent
Externí odkaz:
https://doaj.org/article/f138c478450647da9217f29fea3bd111
Autor:
N V Toroptsova, L I Benevolenskaya
Publikováno v:
Современная ревматология, Vol 0, Iss 1, Pp 78-81 (2008)
Externí odkaz:
https://doaj.org/article/62bfe8cac76d469e91a41a4904af73eb
Autor:
L Ya ROZhINSKAYa, S D ARAPOVA, L K DZERANOVA, N N MOLITVOSLOVOVA, E I MAROVA, A A ShIShKINA, N I SAZONOVA, T O ChERNOVA, A V IL'IN, L I BENEVOLENSKAYa, O A NIKITINSKAYa, T A KOROTKOVA, N V TOROPTsOVA, A V SMIRNOV, N V DEMIN, S S RODIONOVA, Yu V BUKLEMEShEV, A A ShUMSKIY
Publikováno v:
Остеопороз и остеопатии, Vol 10, Iss 3, Pp 24-30 (2007)
В представляемой работе обобщен первый опыт применения Бивалоса в терапии ПМО в России. Целью настоящего исследования являлось изучени
Externí odkaz:
https://doaj.org/article/6e962d8a5f044c3eb1538eb1045a1c0d